What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention in high-bleeding risk: 1 month or 3 months?

Eur Heart J. 2024 Jan 1;45(1):70. doi: 10.1093/eurheartj/ehad728.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Clopidogrel / therapeutic use
  • Hemorrhage / chemically induced
  • Humans
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors* / adverse effects

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel